An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: * Healthy participant, as determined by no clinically significant deviation from normal in physical examination, electrocardiograms (ECGs), and clinical laboratory determinations * Body mass index of 18.0 to 32.0 kg/m2, inclusive, and weight ≥ 50 kg, at screening * Normal renal function at screening as evidenced by an estimated GFR (glomerular filtration rate) \> 80 mL/min/1.732 m2 Exclusion Criteria: * Any medical condition that presents a potential risk to the participant and/or may compromise the objectives of the study, including a history of or active liver disease * Positive anti- John Cunningham virus (JCV) antibody test at Screening * History of allergy to MMF, BMS-986165, related compounds or any significant drug allergy Other protocol defined inclusion/exclusion criteria could apply